Catalyst Pharmaceutical
CPRX
CPRX
117 hedge funds and large institutions have $327M invested in Catalyst Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 41 increasing their positions, 28 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
16% more funds holding
Funds holding: 101 → 117 (+16)
0.03% less ownership
Funds ownership: 59.85% → 59.82% (-0.03%)
65% less call options, than puts
Call options by funds: $377K | Put options by funds: $1.08M
Holders
117
Holding in Top 10
2
Calls
$377K
Puts
$1.08M
Top Buyers
| 1 | +$9.59M | |
| 2 | +$6.24M | |
| 3 | +$5.75M | |
| 4 |
Goldman Sachs
New York
|
+$4.81M |
| 5 |
Prudential Financial
Newark,
New Jersey
|
+$3.3M |
Top Sellers
| 1 | -$19.2M | |
| 2 | -$10M | |
| 3 | -$7.05M | |
| 4 |
BBA
Baker Bros. Advisors
New York
|
-$6.46M |
| 5 |
DMK
David M. Knott
|
-$1.02M |